10X Genomics Inc
(TXG)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -97,846 | -59,949 | -255,099 | -206,147 | -113,161 |
| Depreciation Amortization | 22,394 | 11,494 | 43,619 | 31,913 | 20,493 |
| Accounts receivable | 23,638 | 23,516 | -10,613 | 361 | 16,526 |
| Accounts payable and accrued liabilities | 5,705 | 4,583 | -6,017 | -2,811 | 1,314 |
| Other Working Capital | -10,362 | -6,297 | 18,021 | 277 | -15,893 |
| Other Operating Activity | 48,242 | 10,928 | 194,892 | 135,452 | 75,070 |
| Operating Cash Flow | $-8,229 | $-15,725 | $-15,197 | $-40,955 | $-15,651 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 29,367 | 13,542 | 183,016 | 166,468 | 146,132 |
| PPE Investments | -5,788 | -2,910 | -48,601 | -45,151 | -29,915 |
| Purchase Sale Intangibles | -1,000 | N/A | -923 | -923 | -723 |
| Other Investing Activity | -1,000 | 0 | -923 | -923 | -723 |
| Investing Cash Flow | $22,579 | $10,632 | $133,492 | $120,394 | $115,494 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -5,814 | -5,814 | -5,814 |
| Common Stock Issued | 6,241 | 1,638 | 19,483 | 13,870 | 9,496 |
| Financing Cash Flow | $6,241 | $1,638 | $13,669 | $8,056 | $3,682 |
| Exchange Rate Effect | -51 | -48 | -33 | -110 | -25 |
| Beginning Cash Position | 359,284 | 359,284 | 227,353 | 227,353 | 227,353 |
| End Cash Position | 379,824 | 355,781 | 359,284 | 314,738 | 330,853 |
| Net Cash Flow | $20,540 | $-3,503 | $131,931 | $87,385 | $103,500 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,229 | -15,725 | -15,197 | -40,955 | -15,651 |
| Capital Expenditure | -5,788 | -2,910 | -48,601 | -45,151 | -29,915 |
| Free Cash Flow | -14,017 | -18,635 | -63,798 | -86,106 | -45,566 |